Table 1 Demographic and clinical characteristics of patients

From: Stimulated left DLPFC-nucleus accumbens functional connectivity predicts the anti-depression and anti-anxiety effects of rTMS for depression

Demographics

Early improvers (n = 16)

Early non-improvers (n = 6)

P value

Age (years)

45.00 ± 13.85

28.33 ± 10.84

0.02a

Sex (male/female)

6/10

3/3

0.60b

Education (years)

9.40 ± 2.70

11.83 ± 2.71

0.11a

Age of onset (years)

38.81 ± 13.98

26.17 ± 10.59

0.08a

first-episode/recurrence

9/7

4/2

0.66b

Duration of depressive episode (months)

80.69 ± 116.3

27.25 ± 21.67

0.53a

HAMD

   

 Pre-rTMS

18.50 ± 6.13

17.17 ± 1.45

0.97a

 Post-rTMS

10.94 ± 4.00

15.83 ± 1.47

0.004a

HAMA

   

 Pre-rTMS

20.19 ± 8.55

21.17 ± 6.44

0.76a

 Post-rTMS

10.94 ± 6.00

16.83 ± 5.00

0.03a

  1. HAMD Hamilton Rating Scale for depression, HAMA Hamilton Anxiety Rating Scale, rTMS repetive transcranial magnetic stimulation
  2. The values are illustrated as mean ± SD
  3. aMann Whitney test
  4. bChi-square test